2010•PubMedRequires access

[Expression of Mta-1 and VEGF and their correlation in the endometrial cancer].

Yi-min Yang, Hua Liu, Wenbin Li

Open publisher page 3 citations

Abstract

AIM: To explore the expression of metastasis-associated protein 1(Mta-1) and vascular endothelial growth factor (VEGF) and their correlation in the endometrial cancer. METHODS: In 62 cases of endometrial cancer and 30 cases of normal endomedium, the expression of Mta-1 and VEGF was examined with immunohistochemistry and their correlation with pathological phenotype of the endometrial cancer was analyzed. RESULTS: The expression of Mta-1 and VEGF in endometrial cancer was higher than that in normal endomedium (P<0.01). The expression of Mta-1 and VEGF in endometrial cancer was related to clinical stage, pathologic type, lymph node metastasis and depth of myometrial invasion (P<0.05 or P<0.01). Positive correlation was observed between VEGF and Mta-1 expression(r=0.582, P<0.05). CONCLUSION: Expression of Mta-1 expression and VEGF is positively associated with the development and progression of endometrial cancer.

About this research paper

What this paper is about

AIM: To explore the expression of metastasis-associated protein 1(Mta-1) and vascular endothelial growth factor (VEGF) and their correlation in the endometrial cancer. METHODS: In 62 cases of endometrial cancer and 30 cases of normal endomedium, the expression of Mta-1 and VEGF was examined with immunohistochemistry and their correlation with pathological phenotype of the endometrial cancer was analyzed. RESULTS: The expression of Mta-1 and VEGF in endometrial cancer was higher than that in normal endomedium (P<0.01). The expression of Mta-1 and VEGF in endometrial cancer was related to clinical stage, pathologic type, lymph node metastasis and depth of myometrial invasion (P<0.05 or P<0.01). Positive correlation was observed between VEGF and Mta-1 expression(r=0.582, P<0.05). CONCLUSION: Expression of Mta-1 expression and VEGF is positively associated with the development and progression of endometrial cancer.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM: To explore the expression of metastasis-associated protein 1(Mta-1) and vascular endothelial growth factor (VEGF) and their correlation in the endometrial cancer. METHODS: In 62 cases of endometrial cancer and 30 cases of normal endomedium, the expression of Mta-1 and VEGF was examined with immunohistochemistry and their correlation with pathological phenotype of the endometrial cancer was analyzed. RESULTS: The expression of Mta-1 and VEGF in endometrial cancer was higher than that in normal endomedium (P<0.01). The expression of Mta-1 and VEGF in endometrial cancer was related to clinical stage, pathologic type, lymph node metastasis and depth of myometrial invasion (P<0.05 or P<0.01). Positive correlation was observed between VEGF and Mta-1 expression(r=0.582, P<0.05). CONCLUSION: Expression of Mta-1 expression and VEGF is positively associated with the development and progression of endometrial cancer.

Key concepts: Endometrial cancer, Immunohistochemistry, Vascular endothelial growth factor, Lymph node metastasis, Pathological, VEGF receptors, Medicine, Metastasis

Related papers

Back to paper searchBrowse research topicsOriginal source
[Expression of Mta-1 and VEGF and their correlation in the endometrial cancer]. — Research Paper | ScholarLens